1. Infectious Diseases Unit, the Royal Children’s Hospital Melbourne, Parkville, Victoria, Australia;
2. Infectious Diseases Group and
3. Department of Paediatrics and
4. Infectious Diseases Unit and Migrant Health Service, and
5. Mycobacterial and Migrant Health Research Group, Department of Clinical Research, Children’s University Hospital Basel, University of Basel, Basel, Switzerland;
6. Great Ormond Street Institute of Child Health, University College London, London, United Kingdom;
7. Department of Paediatric Infectious Diseases and Immunology, Evelina London Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom;
8. Hyloris Pharmaceuticals SA, Liège, Belgium;
9. Clinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;
10. Neonatal Intensive Care Unit, Mercy Hospital for Women, Heidelberg, Victoria, Australia;
11. Africa Health Research Institute, Durban, South Africa; and
12. Centenary Institute, University of Sydney, Sydney, New South Wales, Australia
13. Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, the University of Melbourne, Parkville, Victoria, Australia;